M&A Due Diligence
lower-mid-market advisory

The Founder's Defensive Playbook: 10 Questions to Ask Before Signing a PE Term Sheet

Client/Category
Exit Readiness
Industry
B2B Tech & Services
Function
Executive Leadership

The Champagne Trap

The term sheet arrives with a valuation number that validates ten years of missed birthdays, sleepless nights, and near-death experiences. The champagne is chilled. But while you are looking at the headline price, the Private Equity firm is looking at the governance covenants. You see a partnership; they see an asset to be engineered, levered, and sold.

Here is the reality of the 2025 market: The easy exits are gone. According to PitchBook's latest data, the median hold period for PE assets has stretched to nearly six years, creating a massive "exit overhang" of over 12,000 unsold companies. This pressure rolls downhill. It transforms "patient capital" into anxious operators demanding immediate margin expansion.

Most founders negotiate the wrong things. They fight for a 5% higher valuation but surrender control over the budget, the hiring plan, and the exit timing. They sign "standard" terms that are actually subordination agreements in disguise.

If you are a Founder-CEO (Scaling Sarah) staring at a Letter of Intent (LOI), you need to stop reading the marketing deck and start interrogating the deal model. You are not just selling equity; you are hiring a boss. And the statistics are brutal: 71% of founders leave within 18 months of acquisition, often walking away from millions in unrealized earnouts.

The Diagnostic: 10 Questions That Reveal the Real Deal

Do not accept "that's standard market practice" as an answer. Ask these ten questions to expose the mechanics of the partnership.

1. What is the explicit EBITDA bridge to the next exit?

Don't settle for "we'll grow 20% year-over-year." Demand to see the bridge. How much of the target return comes from organic growth versus multiple arbitrage? In a market where multiples are compressing, if their model relies on selling you for 15x when they bought you for 10x, the math is broken. You need to know if the plan requires aggressive cost-cutting (margin expansion) just to make the base case work.

2. How are "Strategic Add-Backs" treated in my earnout calculation?

The PE firm will use aggressive add-backs (synergies, one-time costs) to help you get debt financing. But often, they exclude those same add-backs when calculating your earnout. Structuring earnouts that actually pay out requires alignment. If the bank gets credit for the synergy, so should you. With 92% of recent deals featuring earnouts to bridge valuation gaps, this definition is worth millions.

3. What is the specific budget for the "Value Creation Plan," and whose P&L does it hit?

They will promise a team of experts to help you scale. Great. Who pays for them? If they charge the company $500k/year in "monitoring fees" plus the cost of their preferred consultants, that’s $1M+ of EBITDA drag that you have to offset just to hit your flat budget. Ask for the "fees and expenses" line item in the pro forma model.

4. What is the fund's vintage and remaining lifecycle?

Context is leverage. If you are the first investment in a new 10-year fund, they can be patient. If you are the last investment in a fund that is already seven years old, they are on a shot clock. They must exit in 3-4 years to return capital to LPs. This dictates every operational decision you will make.

5. What are the exact triggers for my removal?

It’s rarely "for cause." It is usually tied to budget variances. If you miss EBITDA by 15% for two consecutive quarters, do you lose your board seat? Do you lose your CEO title? The transition from Founder to CEO is hard enough without a contractual gun to your head. Know the trigger pull before you sign.

6. Do I have a veto on the "Independent" Board Member?

PE boards are typically 2 seats for them, 2 for you, and 1 "Independent." If they choose the Independent, it is 3-against-2. You lose control of your company the day the deal closes. Demand a mutual veto on the 5th seat to ensure true independence.

7. What is your track record of organic growth vs. M&A roll-ups?

Many firms only know how to buy growth (add-ons). If your thesis requires organic scaling, but their "Operating Partners" are actually just M&A integration specialists, you have a capability mismatch. Ask to speak to a CEO in their portfolio who grew organically.

8. How is the "Option Pool" diluted in future rounds?

You’re setting aside 10-15% equity for the management team. If the company needs more cash and the PE firm puts it in, does the management pool get diluted, or is there an anti-dilution top-up? In a "down round" or flat round, the management equity can be wiped out while the PE preference stack stays whole.

9. What is the debt covenant "headroom" on Day 1?

They will pile debt onto your balance sheet. If the leverage ratio covenant is 4.0x and you open at 3.8x, one bad customer churn month puts you in technical default. When you are in default, the PE firm can often take total control or force drastic cuts. Demand at least 20-25% headroom on covenants.

10. Can I reference-check your failed deals?

Every firm has a glossy brochure of winners. Ask to talk to a founder whose company "missed the quarter" or "struggled with integration." How the PE firm behaved when things went wrong matters infinitely more than how they toasted the closing dinner.

Most founders negotiate the valuation but surrender the governance. They sign 'standard' terms that are actually subordination agreements in disguise.
Justin Leader
CEO, Human Renaissance

Red-Lining the Relationship

The term sheet is not just a financial transaction; it is the "Constitution" of your new nation. Once signed, the power dynamics shift permanently. The "70% failure rate" of value creation plans often stems from misalignment locked in at this very stage.

Your Defensive Action Plan:

  • Model the Downside: Run the pro forma model assuming 0% growth. Does the debt service kill the company? If yes, the capital structure is wrong.
  • Define "EBITDA" Carefully: The definition of EBITDA in the credit agreement (for debt) and the management agreement (for your bonus) must be aligned. Do not let them use "Adjusted EBITDA" for the bank but "GAAP EBITDA" for you.
  • Get Operational Diligence: Before you sign, perform your own diligence on their playbook. If they claim to have "proprietary AI tools" or "procurement leverage," ask for the case studies and dollar-value proof.

Remember, the goal is not to kill the deal. The goal is to enter the marriage with your eyes wide open. Why 70% of PE Value Creation Plans Fail isn't usually bad strategy; it's bad governance. Ask the hard questions now, while you still hold the pen.

71%
Founders who exit within 18 months of acquisition
5.9 Years
Median PE Hold Period (2024)
Let's improve what matters.
Justin is here to guide you every step of the way.
Citations

We're ready to respond to your doubts

Understanding your habits and bringing future possibilities into the present.